Market Tracker

09/22 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.95
Delayed Data
As of Sep 22
 +0.03 / +0.43%
Today’s Change
4.11
Today|||52-Week Range
8.38
+18.60%
Year-to-Date

Today’s Trading

Previous close6.92
Today’s open6.95
Day’s range6.86 - 7.04
Volume864,963
Average volume (3 months)1,268,920
Market cap$825.3M
Dividend yield--
Data as of 4:14pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+21.29%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-1.53-7.63%
TGTXTG Therapeutics Inc+0.15+1.27%
BYSIBeyondspring Inc-0.82-2.09%
EGRXEagle Pharmaceutical...+0.23+0.40%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts